Note: The following article synopsis was NOT provided by AAPC. It was created by Find-A-Code/innoviHealth.
Article Overview
This article summarizes an HHS Office of Inspector General look at Medicare Part D billing patterns, including concern areas tied to prescription drug spending and pharmacies flagged for questionable billing. It is useful for compliance, auditing, pharmacy, and revenue cycle audiences that monitor Part D program integrity, fraud risk, and oversight developments.
Why This Topic Matters
Understanding OIG program-integrity focus areas helps organizations track compliance risks, identify billing patterns that may draw scrutiny, and stay current on Medicare Part D oversight trends.
What You Will Learn
What the OIG report is examining in Medicare Part D billing
Why opioid-related spending trends are being highlighted
How the article frames fraud and abuse concerns in Part D program integrity
Which OIG reports are referenced for further reading
Who Should Read This
Compliance professionals
Medical coders
Billing staff
Pharmacy billing teams
Revenue cycle teams
Auditors
Healthcare administrators
Subscribe or sign in to view the full article.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Fully searchable archives - over 5250 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.
Related Articles
Articles are listed in order of calculated relevance.